Almost 30 percent of cancer studies report conflict of interest

A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that conflicts of interest may cause some researchers to report biased results that are favorable to companies.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news161229233.html">Almost 30 percent of cancer studies report conflict of interest</a></p> <p>A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of <i>CANCER</i>, a peer-reviewed journal of the American Cancer Society, the study indicates that conflicts of interest may cause some researchers to report biased results that are favorable to companies.</p>